0001179110-16-022590.txt : 20160401 0001179110-16-022590.hdr.sgml : 20160401 20160401195221 ACCESSION NUMBER: 0001179110-16-022590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160401 FILED AS OF DATE: 20160401 DATE AS OF CHANGE: 20160401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neos Therapeutics, Inc. CENTRAL INDEX KEY: 0001467652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270395455 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 BUSINESS PHONE: 972.408.1360 MAIL ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Garg Vipin K CENTRAL INDEX KEY: 0001515813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37508 FILM NUMBER: 161548597 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 edgar.xml FORM 4 - X0306 4 2016-04-01 0 0001467652 Neos Therapeutics, Inc. NEOS 0001515813 Garg Vipin K C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 10.74 2016-04-01 4 A 0 100000 0 A 2026-04-01 Common Stock 100000 100000 D 25,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017. 75,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017, provided that certain performance-based metrics have been met or satisfied on or before September 30, 2016. /s/ Benjamin Piper, attorney-in-fact 2016-04-01